全基因组分析定义MPN亚型的遗传决定因素并发现CDH22/CD40的性别特异性关联
本研究开展两阶段患者全基因组关联研究,比较原发性血小板增多症(ET)与真性红细胞增多症(PV)及健康对照,并按染色体9p异常、JAK2 V617F负荷和性别分层。发现HBS1L-MYB和GFI1B-GTF3C5等已知关联,以及CDH22/CD40处女性特异性变异与PV易感和ET风险降低相关,多基因风险评分对ET和PV有中等判别能力。
要点
- HBS1L-MYB变异增加ET风险(OR=1.28)并降低PV风险(OR=0.81)。
- GFI1B-GTF3C5变异仅易感PV(OR=1.38)。
- CDH22/CD40变异rs2425786和rs2425788仅在女性中显著,与PV易感(OR=1.3)和ET风险降低(OR=0.75)相关。
核心结论
- 多种胚系变异影响MPN表型,HBS1L-MYB和CDH22/CD40的女性特异性关联是最强决定因素。
研究设计与样本
- 两阶段患者全基因组关联研究,比较MPN亚型(ET、PV)彼此及与健康对照,并按染色体9p异常、JAK2 V617F负荷和性别分层分析。
主要发现
- ET vs PV分析发现HBS1L-MYB增加ET风险(Pmeta=7.93×10^-6,OR=1.28)并降低PV风险(Pmeta=9.43×10^-5,OR=0.81)。
- GFI1B-GTF3C5仅易感PV(Pmeta=1.43×10^-9,OR=1.38)。
- CDH22/CD40处rs2425786和rs2425788仅在女性中显著(Pmeta=2.67×10^-8),与PV易感(Pmeta=.0006,OR=1.3)和ET风险降低(Pmeta=7.82×10^-5,OR=0.75)相关。
- 由31个基因座的48个变异构成的多基因风险评分对ET和PV有中等判别性能(AUC=0.718),按疾病亚型优化后改善(AUCET=0.724,AUCPV=0.755)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To identify genetic variants that influence myeloproliferative neoplasm (MPN) phenotypes, we undertook a 2-stage patient-only genome-wide association study. MPN subtypes (essential thrombocythemia [ET]; polycythemia vera [PV]) were compared with each other to healthy controls and stratified analyses was performed for chromosome 9p aberrations, JAK2 V617F mutation burden, and sex. The ET vs PV analysis identified known associations: (1) at HBS1L-MYB that increased ET risk (Pmeta = 7.93 × 10-6, odds ratio [OR] = 1.28) and reduced PV risk (Pmeta = 9.43 × 10-5, OR = 0.81) and (2) at GFI1B-GTF3C5 that predisposed to PV only (Pmeta = 1.43 × 10-9, OR = 1.38). Two further linked intronic variants, rs2425786 and rs2425788, at CDH22/CD40 were significant in females only (Pmeta = 2.67 × 10-8), with predisposition to PV (Pmeta = .0006, OR = 1.3) and reduction of ET risk (Pmeta = 7.82 × 10-5, OR = 0.75). A polygenic risk score consisting of 48 variants from 31 loci demonstrated moderate discriminative performance for ET and PV (area under the curve [AUC] = 0.718) and was improved by optimization for disease subtype (AUCET = 0.724 and AUCPV = 0.755). Overall, our results reveal that multiple germline variants influence MPN phenotype, with HBS1L-MYB and a novel sex-specific association with CDH22/CD40 being the strongest determinants.
引用
- Tapper WJ, Dawoud AAZ, Score J, et al. Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22/CD40. Blood. 2025. PMID: 41026930. doi:10.1182/blood.2025028489
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。